Donor-Derived Regulatory Dendritic Cell Infusion Maintains Donor-Reactive CD4+CTLA4hi T Cells in Non-Human Primate Renal Allograft Recipients Treated with CD28 Co-Stimulation Blockade

Article English OPEN

Mohamed B. Ezzelarab; Lien Lu; William F. Shufesky; Adrian E. Morelli; Adrian E. Morelli; Angus W. Thomson; Angus W. Thomson;

(2018)

Publisher: Frontiers Media S.A.

Journal: Frontiers in Immunology (issn: 1664-3224)

Related identifiers: doi: 10.3389/fimmu.2018.00250, doi: 10.3389/fimmu.2018.00250/full
Subject: regulatory T cells | dendritic cells | co-stimulation blockade | renal allografts | non-human primates | Immunologic diseases. Allergy | RC581-607

Donor-derived regulatory dendritic cell (DCreg) infusion before transplantation, significantly prolongs renal allograft survival in non-human primates. This is associated with enhanced expression of the immunoregulatory molecules cytotoxic T-lymphocyte-associated antige... View more

Similar Research Results (10)

Donor-Derived Regulatory Dendritic Cell Infusion Maintains Donor-Reactive CD4+CTLA4hi T Cells in Non-Human Primate Renal Allograft Recipients Treated with CD28 Co-Stimulation Blockade (2018)	100%
CXCL9 and CXCL10 are Antagonistic Costimulation Molecules During the Priming of Alloreactive T cell Effectors (2010)	78%
Tracking donor-reactive T cells: evidence for clonal deletion in tolerant kidney transplant patients (2015)	77%
Donor-reactive regulatory T cell frequency increases during acute cellular rejection of lung allografts (2016)	77%
Extrathymic T Cell Deletion and Allogeneic Stem Cell Engraftment Induced with Costimulatory Blockade Is Followed by Central T Cell Tolerance (1998)	74%
Regulatory dendritic cell infusion prolongs kidney allograft survival in non-human primates (2013)	72%
Inhibition of Donor-Reactive CD8+ T Cell Responses by Selective CD28 Blockade Is Independent of Reduced ICOS Expression.	71%
Donor-Reactive T Cell Stimulation History and Precursor Frequency: Barriers to Tolerance Induction (2009)	71%
Targeting apoptosis to induce stable mixed hematopoietic chimerism and long-term allograft survival without myelosuppressive conditioning in mice (2013)	71%
A novel recombinant immunotoxin with the smallest ribosome-inactivating protein Luffin P1: T-cell cytotoxicity and prolongation of allograft survival (2009)	70%

Metrics
No metrics available

Share - Bookmark

Download from
Frontiers in Immunology via DOAJ-Articles (Article, 2018)
Frontiers Media S.A./ Frontiers in Immunology
Cite this publication